Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000834237-21-003919
Filing Date
2021-01-29
Accepted
2021-01-29 09:56:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 us37890u1088_012921.txt SC 13G/A 11723
  Complete submission text file 0000834237-21-003919.txt   13454
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 21568768
SIC: 2834 Pharmaceutical Preparations